Is Liraglutide Injection (Saxenda) in shortage?
Yes. Liraglutide Injection is on FDA’s drug shortage list (limited availability), last updated Sep 22, 2026.
Why it’s in shortage
- Delay in shipping of the drug
- Discontinuation of the manufacture of the drug
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)
Product will be available until discontinuation in January 2027 More from the maker
Maker contact: 833-493-4689
- Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)
Estimated shortage duration: TBD
Maker contact: 833-493-4689
- Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)
Estimated shortage duration: TBD
Maker contact: 833-493-4689
- Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20)
Distributed by Teva
Maker contact: 833-493-4689
- Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)
Distributed by Teva
Maker contact: 833-493-4689
- Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)
Maker contact: 800-631-2174
- Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03)
Maker contact: 800-631-2174
- Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)
Maker contact: 844-824-8426
- Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)
Maker contact: 844-824-8426
- Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)
Discontinuation of the manufacture of the drug
Maker contact: 888-838-2872
FDA recalls of Liraglutide
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Liraglutide Injection:
- Lupin Pharmaceuticals Inc. recalls Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108,
- Novo Nordisk Inc recalls Xultophy 100/3.6 (insulin degludec and liraglutide injection), 100 units/mL and 3.6 mg/mL, 3 mL Prefilled Pen, SAMPLE,
- Novo Nordisk Inc recalls ViCTOZA (liraglutide) injection, 18 mg/3 mL (6 mg/mL), contains: 1 Victoza Pen, Sample Not for Resale, Rx only,
- Novo Nordisk Inc recalls Saxenda (liraglutide) Injection, 18 mg/3 mL (6 mg/mL), 1 x 3 mL Prefilled Pen, Sample. Not for Resale., Rx only, Novo
Liraglutide Injection shortage questions
Is Liraglutide Injection (Saxenda) in shortage?
Yes. Liraglutide Injection is on FDA’s drug shortage list (limited availability), last updated Sep 22, 2026.
Why is there a Liraglutide Injection shortage?
FDA records the reason as: Delay in shipping of the drug; Discontinuation of the manufacture of the drug.
What should I do if I can’t get Liraglutide Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.